Publication | Closed Access

Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition

First-line Targeted TherapyElevated LdhMedicineMelanomaImmunologyImmune Checkpoint InhibitorMelanoma PatientsImmunotherapyOncologyRadiation OncologySkin Cancer